{'fraction_non_alphanumeric': 0.03257707969749855, 'fraction_numerical': 0.03606748109365911, 'mean_word_length': 4.931034482758621, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites

Objective: To evaluate the role of the transjugular intrahepatic portosystemic shunt (TIPS) in the management of patients with refractory ascites. Design: A retrospective study of 25 consecutive patients for whom refractory ascites was the primary indication for TIPS insertion. Setting: Regional liver unit at Freeman Hospital, Newcastle upon Tyne, UK. Participants and interventions: Twelve male and 13 female patients with a mean age of 58 years and mean Child‐Pugh score of 10, treated with TIPS for refractory ascites between July 1992 and September 1995. Main outcome measures: Effect of TIPS on mortality, ascites and hospital admission rate. Results: TIPS was successfully placed in all patients with a 59% mean reduction in portosystemic pressure gradient. Response rate was 68%, 48% and 33% at 1, 3 and 12 months, respectively. Mortality was 48% at 3 months and 67% at 12 months, being higher in those patients older than 60, those with renal impairment and those with higher Child‐Pugh score. Amongst nine patients surviving long term (>12 months) the mean time spent in hospital in the 3 months before TIPS was 35 days and in the year following TIPS 30 days. Patients who died (16 in total) spent a mean of 19 days in hospital before TIPS, 10 never leaving hospital, and 6 who were discharged spent a mean of 19 days post procedure in hospital (mean survival 84 days). Conclusion: TIPS has a limited role in the management of patients with refractory ascites. It is not an appropriate treatment where patients are older than 60, have renal impairment (creatinine >200&mgr;mol/l) or have a Child‐Pugh score greater than 10.